593 related articles for article (PubMed ID: 11034748)
1. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
[TBL] [Abstract][Full Text] [Related]
2. Prevention of chronic NSAID induced upper gastrointestinal toxicity.
Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
Cochrane Database Syst Rev; 2000; 2002(3):CD002296. PubMed ID: 10908548
[TBL] [Abstract][Full Text] [Related]
3. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
5. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
[TBL] [Abstract][Full Text] [Related]
6. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
[TBL] [Abstract][Full Text] [Related]
8. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
Koch M; Dezi A; Ferrario F; Capurso I
Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
[TBL] [Abstract][Full Text] [Related]
9. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
Dajani EZ; Agrawal NM
Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
[TBL] [Abstract][Full Text] [Related]
10. Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials.
Leandro G; Pilotto A; Franceschi M; Bertin T; Lichino E; Di Mario F
Dig Dis Sci; 2001 Sep; 46(9):1924-36. PubMed ID: 11575445
[TBL] [Abstract][Full Text] [Related]
11. Prevention of NSAID-gastropathy.
Ardizzone S; Bianchi Porro G
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
[TBL] [Abstract][Full Text] [Related]
13. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
[TBL] [Abstract][Full Text] [Related]
14. [What treatments can reduce the digestive complications of NSAIDs].
Combe B; Flipo RM
Presse Med; 2003 Nov; 32(37 Pt 2):S33-7. PubMed ID: 14763352
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.
Yang M; He M; Zhao M; Zou B; Liu J; Luo LM; Li QL; He JH; Lei PG
Curr Med Res Opin; 2017 Jun; 33(6):973-980. PubMed ID: 28076696
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
17. [Present position in the prevention and therapy of NSAID-induced ulcers].
Lehmann FS; Beglinger C
Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
[TBL] [Abstract][Full Text] [Related]
18. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
Raskin JB; White RH; Jackson JE; Weaver AL; Tindall EA; Lies RB; Stanton DS
Ann Intern Med; 1995 Sep; 123(5):344-50. PubMed ID: 7625622
[TBL] [Abstract][Full Text] [Related]
19. Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H2-receptor antagonists.
Koch M; Capurso L; Dezi A; Ferrario F; Scarpignato C
Dig Dis; 1995 Jan; 13 Suppl 1():62-74. PubMed ID: 7697903
[TBL] [Abstract][Full Text] [Related]
20. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis?
Goldstein JL
Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S11-5. PubMed ID: 10929893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]